Net Change In Cash - Diffusion Pharmaceuticals Inc (NASDAQ:CRVO) - Alpha Spread
D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 17.47 USD 10.57% Market Closed
Market Cap: 144.2m USD
Have any thoughts about
Diffusion Pharmaceuticals Inc?
Write Note

Diffusion Pharmaceuticals Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Diffusion Pharmaceuticals Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
D
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Net Change in Cash
$13.5m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$4.4B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
29%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$2.9B
CAGR 3-Years
-17%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$24.9B
CAGR 3-Years
-115%
CAGR 5-Years
-40%
CAGR 10-Years
-33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-48%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$21.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Diffusion Pharmaceuticals Inc's Net Change in Cash?
Net Change in Cash
13.5m USD

Based on the financial report for Jun 30, 2024, Diffusion Pharmaceuticals Inc's Net Change in Cash amounts to 13.5m USD.

What is Diffusion Pharmaceuticals Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-7%

Over the last year, the Net Change in Cash growth was 50%. The average annual Net Change in Cash growth rates for Diffusion Pharmaceuticals Inc have been -9% over the past three years , and -7% over the past ten years .

Back to Top